Inactive Instrument
Medicure Inc Stock Toronto S.E.
Stocks
MPH
CA58469E4085
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 10.44M 7.44M 6.42M 5.9M 5.55M 702M 10.52M 69.93M 27.22M 345M 27.92M 27.33M 1.19B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 7.49M 5.34M 4.61M 4.24M 3.99M 504M 7.56M 50.2M 19.54M 247M 20.05M 19.62M 856M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
73.4% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Medicure Inc
| 1 day | -5.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 1997-09-14 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 2022-05-31 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 2019-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 1997-09-14 |
Arnold Naimark
BRD | Director/Board Member | 92 | 2000-02-27 |
Brent Fawkes
BRD | Director/Board Member | 56 | 2013-01-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.23% | +0.16% | - | - | 7.98M | ||
| +3.23% | +2.25% | +65.02% | +113.87% | 54.54B | ||
| +0.04% | +1.20% | +47.67% | +36.75% | 43.86B | ||
| +3.04% | +7.05% | -12.15% | -18.06% | 22.63B | ||
| +3.07% | +7.15% | -1.82% | +392.25% | 20.7B | ||
| +3.08% | +2.14% | +23.06% | -34.52% | 15.84B | ||
| +5.27% | +1.87% | +13.67% | -38.81% | 14.83B | ||
| +0.65% | -0.27% | +26.80% | +174.70% | 13.1B | ||
| +1.44% | +2.94% | +18.51% | - | 12.66B | ||
| +1.92% | +2.43% | +112.68% | +232.59% | 11.68B | ||
| Average | +1.50% | +2.14% | +32.60% | +107.35% | 23.31B | |
| Weighted average by Cap. | +2.22% | +2.15% | +37.14% | +98.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.62M 13.47M 12.39M 11.66M 1.47B 22.09M 147M 57.15M 723M 58.61M 57.36M 2.5B | 28.86M 20.57M 17.75M 16.31M 15.36M 1.94B 29.1M 193M 75.27M 953M 77.2M 75.55M 3.3B |
| Net income | -1.04M -741K -639K -587K -553K -69.9M -1.05M -6.96M -2.71M -34.3M -2.78M -2.72M -119M | -7.1M -5.06M -4.36M -4.01M -3.78M -477M -7.16M -47.55M -18.51M -234M -18.99M -18.58M -811M |
| Net Debt | -6.32M -4.5M -3.88M -3.57M -3.36M -425M -6.37M -42.33M -16.48M -209M -16.9M -16.54M -722M | -2.94M -2.1M -1.81M -1.66M -1.57M -198M -2.97M -19.73M -7.68M -97.2M -7.88M -7.71M -336M |
Employees
-

















